ARXCH
  • Home
  • About
  • Archives
  • Contact
  • Submission
Picture

Vol 3, No 1 (2019): ARxCH

Picture
Picture

Articles
Overview of Selected Novel Drugs Approved in 2018
         Madison Donnelly & Shawn Hodge
Ceiling Dose of Ketorolac in Treatment of Moderate to Severe Acute Pain in an Emergency Department Setting
          Nicole Babiak
Breakthrough Therapy Designation Awarded to Crisanlizumab, a New Treatment Option for Sickle Cell Disease
          Cassandra Kuhn & Olivia Reiber
The Watchman Device: An Alternative Treatment in Atrial Fibrillation
          Anastasia Palmer, Ahmned Mohamed, & Shiader Thao
Electronic Cigarettes: Ongoing Research
         Elizabeth Claus & Vivian Lee
GOLD 2018 Report: A Review
        Jonathan Mitchell
Benefits and Risk of Aspirin as Primary Prevention of Cardiovascular Disease
          Grant Morgan & Thomas Brown
The ARxCH Print Edition 2019
          Grant Morgan

Notice and Disclaimer


Medicine is an ever-changing science.  As new research and clinical experience broaden our knowledge, changes in treatment and drug therapy are required.  The authors and the publisher of this work have checked with sources believed to be reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication.  However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been involved in the preparation or publication of this work warrants that the information contained herein is accurate or complete, and they disclaim all responsibility for any errors or omissions or for the results obtained from use of the information contained in this work.    Readers are encouraged to confirm the information contained herein with other sources.   For example and in particular, readers are advised to check the product information sheet included in the package of each drug they plan to administer to be certain that the information contained in this work is accurate and that changes have not been made in the recommended dose or in the contraindications for administration.

Subscribe to ARxCH

  • Home
  • About
  • Archives
  • Contact
  • Submission